Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 1.850
0.00 (0.00%)
At close: Mar 25, 2026
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 9.91 million as of March 25, 2026. Its market cap has increased by 73.85% in one year.
Market Cap
9.91M
Enterprise Value
9.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.85
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 9.91M, a decrease of -70.54%. That is a compound annual growth rate of -25.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 9.91M | 8.53% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 21.40M |
| Aptamer Group | 20.23M |
| SkinBioTherapeutics | 16.20M |
| Fusion Antibodies | 14.38M |
| Oxford BioDynamics | 8.58M |
| Cizzle Biotechnology Holdings | 7.93M |
| IXICO | 7.23M |
| CRISM Therapeutics | 6.98M |